Key Developments: Accretive Health Inc (AH)
11.11USD
23 May 2013
$0.18 (+1.65%)
$10.93
$10.87
$11.11
$10.76
199,476
855,361
$14.19
$8.55
Latest Key Developments (Source: Significant Developments)
Bernstein Liebhard LLP Announces That A Securities Class Action Has Been Filed Against Accretive Health Inc
Bernstein Liebhard LLP announced that a securities class action has been commenced in the United States District Court for Northern District of Illinois on behalf of all those who purchased or otherwise acquired shares of Accretive Health Inc between May 20, 2010 and February 26, 2013, inclusive (the "Class Period"). Full Article
Accretive Health Inc Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Accretive Health, Inc.
Ryan & Maniskas, LLP announced that a class action lawsuit has been filed in United States District Court for Northern District Of Illinois on behalf of purchasers of Accretive Health Inc common stock during the period between May 20, 2010 and February 26, 2013 (the Class Period). Full Article
Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Accretive Health Inc
Law Offices of Howard G. Smith announced that a class action lawsuit has been filed in the United States District Court for the Northern District of Illinois on behalf of a class (the Class) comprising all purchasers of the securities of Accretive Health Inc between May 20, 2010 and February 26, 2013, inclusive (the Class Period). Full Article
Bronstein, Gewirtz & Grossman, LLC Announces Law Suit Against Accretive Health Inc
Bronstein, Gewirtz & Grossman, LLC announced that they have until July 19, 2013 to file lead plaintiff applications in a securities class action lawsuit against Accretive Health, Inc., if they purchased the Company's securities during the period between May 20, 2010 and February 26, 2013, inclusive (the "Class Period"). This action is pending in the United States District Court for the Northern District of Illinois. The Complaint charges Accretive and other defendants with violations of the Federal Securities Laws. The complaint alleges that throughout the class period defendants failed to disclose the following: (i) that the Company had improperly recognized revenue under certain managed service contracts; (ii) that the Company's financial statements were not prepared in accordance with Generally Accepted Accounting Principles; (iii) that the Company lacked adequate internal and financial controls; and (iv) that, as a result of the foregoing, the Company's financial statements were materially false and misleading at all relevant times. Full Article
Law Office of Brodsky & Smith, LLC Announces That A Class Action Has Been Filed Against Accretive Health Inc
Law Office of Brodsky & Smith, LLC announced that a class action lawsuit has been filed in the United States District Court for the Northern District of Illinois on behalf of all those who purchased or otherwise acquired shares of Accretive Health Inc between May 20, 2010 and February 26, 2013, inclusive (the Class Period). Full Article
Accretive Health Inc Names Stephen Schuckenbrock President and CEO; Mary Tolan As Chairman
Accretive Health Inc announced that Stephen Schuckenbrock, formerly President of Dell Services, has been named President and Chief Executive Officer (CEO) and a member of the Accretive Board of Directors effective on April 3, 2013. Firm co-founder and current President and Chief Executive Officer (CEO) Mary Tolan has been elected Chairman of the Board of Directors. Co-founder and current Chairman of the Board J. Michael Cline will continue to serve as a Director of the Company. Full Article
Law Offices of Todd M. Garber Announces Investigation Of Accretive Health Inc
Law Offices of Todd M. Garber announced that it is investigating potential claims against Accretive Health, Inc. (Accretive or the Company) concerning possible violations of federal securities laws. Accretive provides revenue cycle management services for hospitals and healthcare providers in the United States. The investigation is related to Accretive`s February 26, 2013 announcement that it will postpone the release of the Company`s financial results for the fourth quarter and full-year 2012 because it is evaluating the timing of revenue recognition for its revenue cycle management agreements. In addition, Accretive announced that it was withdrawing the financial guidance that the Company previously provided on November 7, 2012. As a result of this news, the price of Accretive shares declined almost 20%, on heavy trading volume. Full Article
Glancy Binkow & Goldberg LLP Announces Investigation Of Accretive Health Inc
Glancy Binkow & Goldberg LLP announced that it is investigating potential claims on behalf of purchasers of the securities of Accretive Health Inc concerning possible violations of federal securities laws. The investigation focuses on allegations that certain statements issued by Accretive between May 9, 2012 and February 26, 2013 were false and misleading regarding the Company’s business, operations and prospects. The investigation is related to Accretive’s February 26, 2013 announcement that it will postpone the release of the Company’s financial results for the fourth quarter and full-year 2012 because it is evaluating the timing of revenue recognition for its revenue cycle management agreements. In addition, Accretive announced that it was withdrawing the financial guidance that the Company previously provided on November 7, 2012. As a result of this news, the price of Accretive shares declined almost 20%, on heavy trading volume. Full Article
Faruqi & Faruqi, LLP Announces Investigation Of Potential Securities Fraud At Accretive Health Inc
Faruqi & Faruqi, LLP, a national securities law firm, announced that it is investigating potential securities fraud at Accretive Health Inc. The investigation focuses on Accretive Health's February 26, 2013 announcement that it will postpone the release of its financial results for the fourth quarter and full year 2012 because it is evaluating the timing of revenue recognition for its revenue cycle management agreements. Furthermore, the Company stated that it is evaluating its method of revenue recognition, and it may be required to restate prior-period financial statements. Full Article
Harwood Feffer LLP Announces Investigation of Accretive Health Inc
Harwood Feffer LLP announced that it is investigating potential claims against Accretive Health Inc (Accretive Health or the Company) and its officers and directors on behalf of purchasers of Accretive Health common stock concerning false and misleading statements, omissions and fraudulent accounting practices. More specifically, Harwood Feffer is investigating whether certain statements made by the Company between May 9, 2012 and February 26, 2013 regarding the Company's revenue and related projections were false and misleading because the Company engaged in improper revenue recognition practices during such time. Accretive Health is a provider of revenue cycle management services for hospitals and healthcare providers in the United States. On February 26, 2013, Accretive Health announced that it would postpone the release of fourth quarter and full-year financial results because of concerns related to its revenue recognition practices under its revenue cycle management agreements with its customers. Relatedly, the Company announced that it was withdrawing its financial guidance provided on November 12, 1012. The market reacted swiftly to this news on February 27, 2013, causing the Company's stock price to drop nearly 30% in intra-day trading on heavy volume. Full Article
Accretive Health shares tumble after company delays results
- Shares of Accretive Health Inc fell as much as 30 percent on Wednesday as the medical billing services provider withdrew its forecast and indefinitely delayed the filing of its fourth-quarter results, saying it was evaluating the timing of revenue recognition.
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
